| Injectable, cellular-scale optoelectronics with applications for wireless optogenetics T Kim, JG McCall, YH Jung, X Huang, ER Siuda, Y Li, J Song, YM Song, ... Science 340 (6129), 211-216, 2013 | 1300 | 2013 |
| CRH engagement of the locus coeruleus noradrenergic system mediates stress-induced anxiety JG McCall, R Al-Hasani, ER Siuda, DY Hong, AJ Norris, CP Ford, ... Neuron 87 (3), 605-620, 2015 | 661 | 2015 |
| Locus coeruleus to basolateral amygdala noradrenergic projections promote anxiety-like behavior JG McCall, ER Siuda, DL Bhatti, LA Lawson, ZA McElligott, GD Stuber, ... Elife 6, e18247, 2017 | 313 | 2017 |
| Distinct mutants of retrograde intraflagellar transport (IFT) share similar morphological and molecular defects G Piperno, E Siuda, S Henderson, M Segil, H Vaananen, M Sassaroli The Journal of cell biology 143 (6), 1591-1601, 1998 | 241 | 1998 |
| Hippocampal AMPA receptor gating controlled by both TARP and cornichon proteins AS Kato, MB Gill, MT Ho, H Yu, Y Tu, ER Siuda, H Wang, YW Qian, ... Neuron 68 (6), 1082-1096, 2010 | 196 | 2010 |
| New transmembrane AMPA receptor regulatory protein isoform, γ-7, differentially regulates AMPA receptors AS Kato, W Zhou, AD Milstein, MD Knierman, ER Siuda, JE Dotzlaf, H Yu, ... Journal of Neuroscience 27 (18), 4969-4977, 2007 | 191 | 2007 |
| Biased mu-opioid receptor ligands: a promising new generation of pain therapeutics ER Siuda, R Carr III, DH Rominger, JD Violin Current opinion in pharmacology 32, 77-84, 2017 | 166 | 2017 |
| Spatiotemporal control of opioid signaling and behavior ER Siuda, BA Copits, MJ Schmidt, MA Baird, R Al-Hasani, WJ Planer, ... Neuron 86 (4), 923-935, 2015 | 163 | 2015 |
| AMPA receptor subunit-specific regulation by a distinct family of type II TARPs AS Kato, ER Siuda, ES Nisenbaum, DS Bredt Neuron 59 (6), 986-996, 2008 | 160 | 2008 |
| LY503430, a novel α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of … TK Murray, K Whalley, CS Robinson, MA Ward, CA Hicks, D Lodge, ... The Journal of Pharmacology and Experimental Therapeutics 306 (2), 752-762, 2003 | 131 | 2003 |
| Optodynamic simulation of β-adrenergic receptor signalling ER Siuda, JG McCall, R Al-Hasani, G Shin, S Il Park, MJ Schmidt, ... Nature communications 6 (1), 8480, 2015 | 117 | 2015 |
| NACHO mediates nicotinic acetylcholine receptor function throughout the brain JA Matta, S Gu, WB Davini, B Lord, ER Siuda, AW Harrington, DS Bredt Cell reports 19 (4), 688-696, 2017 | 92 | 2017 |
| Ultraminiaturized photovoltaic and radio frequency powered optoelectronic systems for wireless optogenetics SI Park, G Shin, A Banks, JG McCall, ER Siuda, MJ Schmidt, HU Chung, ... Journal of neural engineering 12 (5), 056002, 2015 | 88 | 2015 |
| Inflammation and nerve injury minimally affect mouse voluntary behaviors proposed as indicators of pain TD Sheahan, ER Siuda, MR Bruchas, AJ Shepherd, DP Mohapatra, ... Neurobiology of Pain 2, 1-12, 2017 | 75 | 2017 |
| Glutamate receptor δ2 associates with metabotropic glutamate receptor 1 (mGluR1), protein kinase Cγ, and canonical transient receptor potential 3 and regulates mGluR1-mediated … AS Kato, MD Knierman, ER Siuda, JTR Isaac, ES Nisenbaum, DS Bredt Journal of Neuroscience 32 (44), 15296-15308, 2012 | 68 | 2012 |
| Molecular determinants responsible for differences in desensitization kinetics of AMPA receptor splice variants JC Quirk, ER Siuda, ES Nisenbaum Journal of Neuroscience 24 (50), 11416-11420, 2004 | 58 | 2004 |
| Chemogenetic and optogenetic activation of gαs signaling in the basolateral amygdala induces acute and social anxiety-like states ER Siuda, R Al-Hasani, JG McCall, DL Bhatti, MR Bruchas Neuropsychopharmacology 41 (8), 2011-2023, 2016 | 54 | 2016 |
| Serine 363 is required for nociceptin/orphanin FQ opioid receptor (NOPR) desensitization, internalization, and arrestin signaling NR Zhang, W Planer, ER Siuda, HC Zhao, L Stickler, SD Chang, MA Baird, ... Journal of Biological Chemistry 287 (50), 42019-42030, 2012 | 46 | 2012 |
| Innovative drug development for headache disorders: glutamate KW Johnson, ES Nisenbaum, MP Johnson, DK Dieckman, ... Frontiers in headache research 16, 185-194, 2008 | 39 | 2008 |
| TRV0109101, a G protein-biased agonist of the µ-opioid receptor, does not promote opioid-induced mechanical allodynia following chronic administration M Koblish, R Carr III, ER Siuda, DH Rominger, W Gowen-MacDonald, ... The Journal of pharmacology and experimental therapeutics 362 (2), 254-262, 2017 | 38 | 2017 |
